ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:02:32 iorio@ebi.ac.uk

Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual Feature analysis: gain_cnaPANCAN213_(MCM3)


Feature details and cell panel numbers

Binary feature equal to 1 for samples having the genomic region(s) cnaPANCAN213_(MCM3) amplified (see genomic region decoding file for further infos on this region)

Number of cell lines positive for this feature: 54


Statistically significant associations identified = 3

association id	FEATURE	Drug id	Propr	Public	Drug Name	Drug Target	N FEATURE pos	N FEATURE neg	log max Conc tested	FEATURE neg logIC50 MEAN	FEATURE pos logIC50 MEAN	FEATURE deltaMEAN IC50	FEATURE IC50 effectSize	FEATURE neg Glass delta	FEATURE pos Glass delta	ANOVA FEATURE pval	Tissue ANOVA pval	MSI ANOVA pval	ANOVA FEATURE FDR %
a409	gain_cnaPANCAN213_(MCM3)	1091	1	1	BMS-536924	IGF1R	52	871	1.39	2.15	2.68	0.531	0.45	0.45	0.51 .	4.9e-04	1.41e-12	6.35e-01	20
a421	gain_cnaPANCAN213_(MCM3)	1003	1	1	Camptothecin	TOP1	47	799	-2.3	-4.1	-3.03	1.07	0.6 .	0.62 .	0.46	5.15e-04	3.35e-23	1.06e-01	20
a435	gain_cnaPANCAN213_(MCM3)	1012	1	1	Vorinostat	HDAC inhibitor Class I, IIa, IIb, IV	47	801	2.3	0.953	1.75	0.796	0.68 .	0.7 .	0.53 .	5.34e-04	5.59e-46	3.96e-01	20

All-tests volcano plot